Wayne Remell Walker Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

Wayne Remell Walker is Director of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 20,625 shares of PMCB, which is worth approximately $16,293. The most recent transaction as insider was on Dec 12, 2025, when has been sold 16,875 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $17,212. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K

n/a 3M change

n/a 12M change

Total Value Held $16,293

WAYNE REMELL WALKER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 12 2025	SELL Payment of exercise price or tax liability	$17,212 $1.02 p/Share	16,875 Reduced 45.0%	20,625 Common Stock
Dec 12 2025	BUY Grant, award, or other acquisition	-	37,500 Added 50.0%	37,500 Common Stock

Also insider at

PBI

PITNEY BOWES INC Industrials

POWW

AMMO, INC. Industrials

WRAP

WRAP TECHNOLOGIES, INC. Technology

AYRO

AYRO, Inc. Consumer Cyclical

Director

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

WRW